Skip to main content

Animations

MJFF Publications

201 - 210 of 6284 Results
Title
Year
  • Year
  • 2018
  • 2022
  • 2022
  • 2016
  • 2021
  • 2022
  • 2022
  • 2021
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-018-05892-0
    Citation Count: 434
  • Summary Details
    OPEN
    Title: More of less: Novel multi-ome profiling of single human neurons
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2022.100110
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainres.2022.147781
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Computer keyboard interaction as an indicator of early Parkinson’s disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/srep34468
    Citation Count: 98
  • Summary Details
    OPEN
    Title: Structural basis of polyamine transport by human ATP13A2 (PARK9)
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Reply to: “Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1‐Associated Parkinson's Disease”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29131
    Citation Count: 0
  • Summary Details
    OPEN
    Title: No Evidence That Glucosylsphingosine Is a Biomarker for Parkinson's Disease: Statistical Differences Do Not Necessarily Indicate Biological Significance
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28935
    Citation Count: 5
  • Summary Details
    OPEN
    Title: In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung
    Journal Name: Brain Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.brainres.2021.147503
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Detecting Motor Impairment in Early Parkinson’s Disease via Natural Typing Interaction With Keyboards: Validation of the neuroQWERTY Approach in an Uncontrolled At-Home Setting
    Journal Name: Journal of Medical Internet Research
    Publisher: JMIR Publications Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.2196/jmir.9462
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Circular RNA expression and regulatory network prediction in posterior cingulate astrocytes in elderly subjects
    Journal Name: BMC Genomics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12864-018-4670-5
    Citation Count: 34
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.